Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

This fact sheet discusses cannabis health risks based on frequency of use, the form consumed, and a patient’s other therapies ...

The HHS will not end funding for the Women's Health Initiative, a major ongoing study started in 1992 that has produced 2400 papers.

Cytisinicline significantly increased the likelihood of quitting and reduced nicotine cravings in adult smokers, according to findings from a second phase 3 smoking cessation trial.

Adolescents with food allergy had 2.83 food allergic reactions per 100 person-months, just under half of which met the criteria for anaphylaxis.

Patients with severe asthma (4.6% of asthma patients) are more likely to be female, older, and have higher BMI than those with non-severe asthma.

The USDA withdrew a proposed rule requiring poultry companies to keep salmonella levels below a set threshold.

Enrollment in the school-based asthma therapy program increased asthma control rates among children and decreased health care utilization.

Pertussis rates so far in 2025 are at least twice as high as this time last year, with three pediatric deaths reported in the last 6 months.

The FDA has expanded the approval of Dextenza (dexamethasone ophthalmic insert) to include pediatric treatment.

Taletrectinib can be effective in patients with TKI-naïve or TKI-pretreated advanced NSCLC, a pooled analysis suggests.

Inhaled corticosteroid use in the afternoon vs morning was associated with better overnight lung function in atopic asthma.